Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

734 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PPAR Agonists and Metabolic Syndrome: An Established Role?
Botta M, Audano M, Sahebkar A, Sirtori CR, Mitro N, Ruscica M. Botta M, et al. Int J Mol Sci. 2018 Apr 14;19(4):1197. doi: 10.3390/ijms19041197. Int J Mol Sci. 2018. PMID: 29662003 Free PMC article. Review.
Nutraceutical approach for the management of cardiovascular risk - a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study.
Ruscica M, Pavanello C, Gandini S, Macchi C, Botta M, Dall'Orto D, Del Puppo M, Bertolotti M, Bosisio R, Mombelli G, Sirtori CR, Calabresi L, Magni P. Ruscica M, et al. Among authors: botta m. Nutr J. 2019 Feb 22;18(1):13. doi: 10.1186/s12937-019-0438-2. Nutr J. 2019. PMID: 30795775 Free PMC article. Clinical Trial.
Correction to: Nutraceutical approach for the management of cardiovascular risk - a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study.
Ruscica M, Pavanello C, Gandini S, Macchi C, Botta M, Dall'Orto D, Del Puppo M, Bertolotti M, Bosisio R, Mombelli G, Sirtori CR, Calabresi L, Magni P. Ruscica M, et al. Among authors: botta m. Nutr J. 2019 Sep 9;18(1):54. doi: 10.1186/s12937-019-0483-x. Nutr J. 2019. PMID: 31500629 Free PMC article.
Plasma PCSK9 levels and lipoprotein distribution are preserved in carriers of genetic HDL disorders.
Ruscica M, Simonelli S, Botta M, Ossoli A, Lupo MG, Magni P, Corsini A, Arca M, Pisciotta L, Veglia F, Franceschini G, Ferri N, Calabresi L. Ruscica M, et al. Among authors: botta m. Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Sep;1863(9):991-997. doi: 10.1016/j.bbalip.2018.05.015. Epub 2018 May 29. Biochim Biophys Acta Mol Cell Biol Lipids. 2018. PMID: 29852278
From lipoprotein apheresis to proprotein convertase subtilisin/kexin type 9 inhibitors: Impact on low-density lipoprotein cholesterol and C-reactive protein levels in cardiovascular disease patients.
Zenti MG, Altomari A, Lupo MG, Botta M, Bonora E, Corsini A, Ruscica M, Ferri N. Zenti MG, et al. Among authors: botta m. Eur J Prev Cardiol. 2018 Nov;25(17):1843-1851. doi: 10.1177/2047487318792626. Epub 2018 Jul 30. Eur J Prev Cardiol. 2018. PMID: 30058841
Circulating Levels of Proprotein Convertase Subtilisin/Kexin Type 9 and Arterial Stiffness in a Large Population Sample: Data From the Brisighella Heart Study.
Ruscica M, Ferri N, Fogacci F, Rosticci M, Botta M, Marchiano S, Magni P, D'Addato S, Giovannini M, Borghi C, Cicero AFG; Brisighella Heart Study Group. Ruscica M, et al. Among authors: botta m. J Am Heart Assoc. 2017 May 3;6(5):e005764. doi: 10.1161/JAHA.117.005764. J Am Heart Assoc. 2017. PMID: 28468788 Free PMC article.
Body composition and metabolic changes during a 520-day mission simulation to Mars.
Strollo F, Macchi C, Eberini I, Masini MA, Botta M, Vassilieva G, Nichiporuk I, Monici M, Santucci D, Celotti F, Magni P, Ruscica M. Strollo F, et al. Among authors: botta m. J Endocrinol Invest. 2018 Nov;41(11):1267-1273. doi: 10.1007/s40618-018-0861-9. Epub 2018 Mar 12. J Endocrinol Invest. 2018. PMID: 29532423 Free article.
PCSK9 deficiency reduces insulin secretion and promotes glucose intolerance: the role of the low-density lipoprotein receptor.
Da Dalt L, Ruscica M, Bonacina F, Balzarotti G, Dhyani A, Di Cairano E, Baragetti A, Arnaboldi L, De Metrio S, Pellegatta F, Grigore L, Botta M, Macchi C, Uboldi P, Perego C, Catapano AL, Norata GD. Da Dalt L, et al. Among authors: botta m. Eur Heart J. 2019 Jan 21;40(4):357-368. doi: 10.1093/eurheartj/ehy357. Eur Heart J. 2019. PMID: 29982592 Free article.
734 results